Alaunos Therapeutics | ZIOP - Assets


Alaunos Therapeutics reported $1.88M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Amgen USD 92.5B 1.92B Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
Baxter International USD 19.85B 209M Mar/2026
Biogen USD 29.48B 43.6M Mar/2026
Bioline Rx USD 39.8M 3.47M Sep/2025
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Celltrion KRW 759.44B 20.32T Dec/2025
Corcept Therapeutics USD 814.88M 21.77M Mar/2026
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Curis USD 19.97M 9.27M Dec/2025
Deva Holding AS TRY 12.93B 1.83B Sep/2023
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Divis Laboratories Ltd INR 200.33B 18.82B Mar/2026
Gilead Sciences USD 56.28B 2.74B Mar/2026
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Incyte USD 7.34B 381.14M Mar/2026
Intrexon USD 73.16M 77.88M Jun/2024
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Kangmei Pharma CNY 13.31B 375.64M Mar/2026
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 63.57M 2.83M Dec/2025
Merck USD 128.68B 8.18B Mar/2026
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Novartis USD 118.53B 7.58B Mar/2026
Organigram Holdings CAD 530.67M 31.54M Dec/2025
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Pfizer USD 207.62B 542M Mar/2026
Pharma Mar EUR 385.26M 9.82M Mar/2026
PTC Therapeutics USD 2.87B 29.66M Mar/2026
Qiagen NV USD 6.3B 257.54M Dec/2025
Regeneron Pharmaceuticals USD 40.87B 310.1M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sangamo BioSciences USD 97.56M 11.39M Jun/2025
Sartorius EUR 9.87B 154.9M Mar/2026
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
TG Therapeutics USD 1.53B 465.58M Mar/2026
Tilray USD 2.1B 15.95M Sep/2025
Verastem USD 246.44M 69.59M Dec/2025
Zealand Pharma A/S 15.95B 848.45M Dec/2025
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026